- Home
- RDY vs XP Comparison
RDY vs XP Comparison
Compare RDY & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- XP
- Stock Information
- Founded
- RDY 1984
- XP 2001
- Country
- RDY India
- XP Cayman Islands
- Employees
- RDY N/A
- XP N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- XP Investment Bankers/Brokers/Service
- Sector
- RDY Health Care
- XP Finance
- Exchange
- RDY Nasdaq
- XP Nasdaq
- Market Cap
- RDY 11.8B
- XP 9.8B
- IPO Year
- RDY N/A
- XP 2019
- Fundamental
- Price
- RDY $14.77
- XP $19.05
- Analyst Decision
- RDY Strong Buy
- XP Strong Buy
- Analyst Count
- RDY 2
- XP 5
- Target Price
- RDY $16.95
- XP $23.80
- AVG Volume (30 Days)
- RDY 785.4K
- XP 8.1M
- Earning Date
- RDY 11-04-2025
- XP 08-18-2025
- Dividend Yield
- RDY 0.49%
- XP 7.32%
- EPS Growth
- RDY 2.20
- XP 18.07
- EPS
- RDY 0.79
- XP 1.67
- Revenue
- RDY $3,897,394,052.00
- XP $3,085,301,717.00
- Revenue This Year
- RDY $7.33
- XP $18.06
- Revenue Next Year
- RDY $1.96
- XP $12.97
- P/E Ratio
- RDY $18.52
- XP $11.29
- Revenue Growth
- RDY 15.86
- XP 6.65
- 52 Week Low
- RDY $12.26
- XP $10.82
- 52 Week High
- RDY $16.19
- XP $20.64
- Technical
- Relative Strength Index (RSI)
- RDY 62.43
- XP 53.05
- Support Level
- RDY $14.60
- XP N/A
- Resistance Level
- RDY $14.85
- XP $19.19
- Average True Range (ATR)
- RDY 0.15
- XP 0.52
- MACD
- RDY 0.06
- XP -0.55
- Stochastic Oscillator
- RDY 89.10
- XP 98.42
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.